The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Annual MeetingFull Access

Philadelphia, May 18-23: The 21st-Century Psychiatrist

APA’s 155TH ANNUAL MEETING: Course Guide
Published Online:https://doi.org/10.1176/pn.37.2.0023

More than a hundred Category 1 continuing medical education courses will be offered at the 155th Annual Meeting of the American Psychiatric Association in May. The courses are in keeping with the goal of presenting a well-planned, highly structured, educational experience for participants.

Admission to all courses, which will be offered in half-day and full-day formats, requires an annual meeting badge and course ticket. Advance enrollment for the CME courses is open to all annual meeting registrants.

You are encouraged to enroll early during the advance enrollment period to avoid the potential disappointment of discovering that your selected courses have been fully subscribed. Please note that requests will be processed on a first-come, first-served basis. Complete course descriptions appear in this section of Psychiatric News and in the CME course brochure, which is included in the Advance Registration Information Packet. The packet was mailed earlier this month; if you do not receive your packet by February 1, refer to the Original article: box below.

Please use the Advance Registration and Course Enrollment Form combined with the course brochure when making your selections.

The fees for the courses are as follows: half day (four credit hours): advance, $95, and on site, $125; full day (six credit hours): advance, $150, and on site $175; full day (eight credit hours): advance, $190, and on site, $250.

The maximum number of participants for each course is listed in this section, as are the date, time, and fee. If the appropriate fees are not received with your advance registration for both the meeting and selected courses, course spaces will not be reserved for you. Fees must be paid in U.S. dollars.

Advance enrollment closes April 13 for U.S. registrants, and April 6 for all others. Tickets for CME courses not sold by April 13 will go on sale to all registrants at 10 a.m. on Saturday, May 18, at the Course Enrollment Area in the Pennsylvania Convention Center. No one will be able to purchase course tickets until after registering for the annual meeting. The registration area will be located in Halls A-C, Exhibit Hall Level.

After the advance enrollment deadline, absolutely no refunds will be granted or changes in course selections permitted. Written notices of cancellation or changes received postmarked by the deadline will be honored, less a $10 processing fee. These written notifications should be addressed to CME Course Coordinator, APA, 1400 K Street, N.W., Washington, D.C., 20005.

SATURDAY, MAY 18, 2002

COURSE 1: COMPUTER-ASSISTED DIAGNOSTIC INTERVIEW.Co-Directors: Paul R. Miller, M.D., Charles Chiu, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) summarize research showing that CADI’s diagnostic precision is reliable, valid, and complete, equal to gold standards (SCID, Consensus), and significantly better than traditional diagnostic interviews; (2) explain how to use CADI with the computer and/or Palm Pilot; and (3) identify when and how to use CADI in clinical practice and research. Course Level: This is an intermediate course. Participants should have familiarity with PC, Windows, and the DSM-IV. Sat., May 18, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 2: ANTIPSYCHOTIC-INDUCED MOVEMENT DISORDERS: ASSESSMENT AND TREATMENT.Director: Leonardo Cortese, M.D. Faculty: Richard Williams, M.D., Michael Caligiuri, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) classify the types of movement disorders; (2) list clinical features, differential diagnosis, and risk factors of all four types of antipsychotic-induced movement disorders; (3) understand treatment modalities of all four types of extrapyramidal syndromes (EPS); (4) examine a patient for movement disorders; (5) identify EPS through video clips of patients with a vast array of movement disorders; and (6) understand the benefit of using instrumentation in the assessment of EPS. Course Level: This is an intermediate course. Participants should have a basic understanding of antipsychotic medication, but no specific or comprehensive background knowledge is required to learn the material of this course. This is a repeat of a course given last year. Sat., May 18, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 3: ADD IN CHILDREN AND ADOLESCENTS.Director: Thomas E. Brown, Ph.D. Faculty: Jefferson B. Prince, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize types of child and adolescent attention-deficit disorders (ADDs), (2) assess and diagnose ADDs using updated instruments and methods, (3) select appropriate medications for ADDs with comorbid conditions, and (4) design multimodal treatment programs for ADD children and adolescents. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sat., May 18, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 75.

COURSE 4: WRITING ABOUT CLINICAL EXPERIENCES.Director: John S. Strauss, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) appreciate the details, depth, and richness of a clinical experience, and (2) describe these experiences in writing. Course Level: This is a basic course. The only background requirement of participants (of any discipline or orientation) is that they have experience as clinicians and be willing to try. Sat., May 18, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 5: ECT IN NEUROLOGICAL DISORDERS.Co-Directors: Georgios Petrides, M.D., Charles H. Kellner, M.D. Faculty: C. Edward Coffey, M.D., Raymond A. Faber, M.D., Max Fink, M.D., Chitra Malur, M.D. Educational Objective: At the conclusion of the course, the practitioner will be able to: (1) identify and select those patients with neurological disorders for whom ECT may be useful, and (2) manage the technical requirements for safe ECT. Course Level: This is an intermediate course for practitioners who have an interest in broadened application of ECT to such neurological disorders as delirium, dementia, intractable seizures, catatonia, NMS, Parkinson's disease, and the mentally ill with brain lesions. This is a revision of a course given last year. Sat., May 18, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 6: BASIC CONCEPTS IN ADMINISTRATIVE PSYCHIATRY: THEORY, HUMAN RESOURCES, AND FISCAL MANAGEMENT.APA Committee on Psychiatry in the Workplace and Academy of Organizational and Occupational Psychiatry.Co-Directors: Christopher G. Fichtner, M.D., Thomas A. Simpatico, M.D. Faculty: L. Mark Russakoff, M.D., Stuart B. Silver, M.D., S. Atezaz Saeed, M.D., Shivkumar Hatti, M.D. Educational Objective: At the conclusion of this course, the participant should be able to demonstrate familiarity with theories, principles, concepts, and developments relevant to administrative psychiatry and their applications in psychiatric service systems. Course Level: This is a basic course. No previous experience or knowledge is required. Participants are not required to take the two-course series. The two-course series is suggested for those seeking certification. Sat., May 18, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 50. A companion course on this topic will be offered on Sun., May 19, 9-4. See Course 23 for details.

COURSE 7: INTERPERSONAL PSYCHOTHERAPY.Director: Scott P. Stuart, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) conduct interpersonal psychotherapy treatment (IPT), (2) demonstrate a knowledge of the research regarding IPT, and (3) deal effectively with difficult and resistant patients using IPT. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sat., May 18, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 25. An intermediate course on this topic will be offered on Wed., May 22, 8-12. See Course 81 for details.

COURSE 8: PERSONALITY AND POLITICAL BEHAVIOR. Director: Jerrold M. Post, M.D. Educational Objective: At the conclusion of this course, the participant should be able to demonstrate an enhanced understanding of the manner in which psychological processes affect political processes, including the psychology of leadership and leader-follower relationships, with particular emphasis on charismatic movements and of the psychological foundations of political terrorism, ethnic/nationalist hatred, and genocidal violence. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sat., May 18, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 9: PSYCHIATRY UPDATE FOR THE INTERNATIONAL SPANISH-SPEAKING COLLEAGUE (IN SPANISH).Director: Gabriel Kaplan, M.D. Faculty: Javier I. Escobar, M.D., Jorge R. Petit, M.D., Eduardo Dunayevich, M.D., Rodrigo A. Pizarro, M.D., Dario F. Mirski, M.D., Ana Kaplan, M.D. Educational Objective: At the conclusion of this course, the participant should be able to summarize recent advances in the treatment of major psychiatric diagnoses for all ages. Course Level: This is an intermediate course. Participants must be Spanish speaking. Sat., May 18, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 10: MULTIMODAL TREATMENT OF EATING DISORDERS.Co-Directors: Kathryn J. Zerbe, M.D., Mae S. Sokol, M.D. Educational Objective: At the conclusion of this course, the participant should obtain a greater repertoire of interventions, such as pharmacological, psychodynamic, educational, nutritional, and cognitive-behavioral interventions in dealing with patients with eating disorders. Course Level: This is an advanced course. Participants should have knowledge of evaluation and treatment of eating disorders. This is a revision of a course given last year. Sat., May 18, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 50. A basic course on this topic will be offered on Sun., May 19, 9-4. See Course 25 for details.

COURSE 11: OUTCOMES: USE OF RATING SCALES.Co-Directors: Luis F. Ramirez, M.D., Martha Sajatovic, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize the differences between outcomes and measurements, (2) determine the type of scales to use according to the specific program or purpose, and (3) become familiar with the interviewing and statistical techniques necessary to prepare a solid evaluation strategy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sat., May 18, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 12: EVIDENCE-BASED MANAGEMENT OF SAD: FOCUS ON LIGHT THERAPY.Co-Directors: Raymond W. Lam, M.D., Anthony J. Levitt, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) diagnose SAD, (2) use light therapy in clinical practice to treat SAD and other conditions, and (3) identify management issues in the use of light therapy and medications for SAD. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Sat., May 18, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50. A similar course on this topic will be offered on Sun., May 19, 1-5. See Course 38 for details.

COURSE 13: NEUROENDOCRINOLOGY IN MOOD DISORDER: DYSREGULATION AND TREATMENT.Co-Directors: Mark A. Frye, M.D., Natalie L. Rasgon, M.D. Faculty: D. Jeffrey Newport, M.D., Stuart N. Seidman, M.D. Educational Objective: At the conclusion of this course, the participant should be able to better understand various neuroendocrine aspects of mood disorders and update his/her knowledge of the possible treatment strategies for mood disorders involving neuroendocrine dysfunction. Course Level: This is a basic course. No previous experience or knowledge is required. Sat., May 18, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 75.

COURSE 14: Withdrawn

COURSE 15: THE EVALUATION AND MANAGEMENT OF PAIN.Director: Steven A. King, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand current concepts of pain and JCAHO pain standards, (2) become familiar with classification systems of pain, (3) identify the problem of pain in special populations, and (4) achieve proficiency in the management of pain. Course Level: This course is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Sat., May 18, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 125.

COURSE 16: DREAM TRANSLATION: ONE EMPIRICALLY BASED APPROACH.Director: Milton Kramer, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand that there is a scientific basis to the search for the meaning of a dream, and (2) apply a methodology to establish a dream’s meaning. Course Level: This is a basic course. No experience or knowledge is required. This is a revision of a course given last year. Sat., May 18, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

SUNDAY, MAY 19, 2002

COURSE 17: DSM-IV-TR CULTURAL FORMULATIONS: DIAGNOSIS AND THERAPY. Director: Russell F. Lim, M.D. Faculty: J. Charles Ndlela, M.D., Candace M. Fleming, Ph.D., Roberto Lewis-Fernandez, M.D., Francis G. Lu, M.D., Michael W. Smith, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand and describe the five parts of the DSM-IV outline for cultural formulation; (2) apply the cultural formulation to the treatment of African-American, Asian, Hispanic, and American-Indian patients; and (3) recognize how ethnicity affects psychopharmacology and psychotherapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sun., May 19, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 18: THE PSYCHIATRIST AS EXPERT WITNESS.Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be able to give more effective expert witness testimony in civil and criminal trials. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Sun., May 19, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 19: TRAINING IN THE USE OF THE POSITIVE AND NEGATIVE SYNDROME SCALE.Co-Directors: Lewis A. Opler, M.D., Paul M. Ramirez, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify positive, negative, and general psychopathological symptoms in schizophrenia; (2) utilize the structured clinical interview for the Positive and Negative Syndrome Scale (PANSS) in clinical or research settings; and (3) use the PANSS in rating symptoms. Course Level: This is an intermediate course. Participants should have some experience interviewing patients with schizophrenia and other psychotic disorders. This is a revision of a course given last year. Sun., May 19, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 20: THE EVALUATION AND IDENTIFICATION OF THE MAJOR DEMENTIAS.Director: Raymond A. Faber, M.D. Faculty: Kevin F. Gray, M.D., Randolph B. Schiffer, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) evaluate all major cognitive and higher cortical functions, (2) utilize any of several cognitive and executive function screening batteries, (3) recognize the most common presentations and course of Alzheimer’s disease and appreciate the behavioral disorders that most frequently complicate Alzheimer’s disease, and (4) differentiate Lewy body dementia, frontotemporal dementias, and vascular dementias for Alzheimer’s disease. Course Level: This is an intermediate course. Participants should have experience in treating patients with dementia. This is a revision of a course given last year. Sun., May 19, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 21: ANTICONVULSANTS IN BIPOLAR DISORDER.Co-Directors: Joseph R. Calabrese, M.D., Mark A. Frye, M.D. Faculty: Terence A. Ketter, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) treat bipolar disorder with divalproex, carbamazepine, lamotrigine, gabapentin, and topiramate; (2) have familiarity with the clinical pharmacology of the anticonvulsants available for use in adults; and (3) use algorithms in the treatment of bipolar disorder. Course Level: This is an intermediate course. Participants should be interested in gathering additional expertise in the pharmacologic management of bipolar disorder with anticonvulsant medication. This is a revision of a course given last year. Sun., May 19, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 250.

COURSE 22: APPRECIATING AND ALLEVIATING SPOUSAL CAREGIVER BURDEN IN DEMENTIA.Co-Directors: Sheila M. Loboprabhu, M.D., Kimberly A. Arlinghaus, M.D. Faculty: Ellen F. Barr, M.S.W., James W. Lomax II, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand experiential, spiritual, ethical, and forensic aspects of spousal caregiving for the patient with dementia; (2) understand the effects of dementia on the marital bond from a marital therapy perspective; (3) relate attachment theory to spousal caregiving in dementia; and (4) integrate couples therapy with pharmacologic treatments in the care of patients with dementia. Course Level: This is a basic course. No previous experience or knowledge is required. Sun., May 19, 8-12; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 23: BASIC CONCEPTS IN ADMINISTRATIVE PSYCHIATRY: CARE MANAGEMENT, LAW, AND ETHICS.Co-Directors: Christopher G. Fichtner, M.D., Wesley Sowers, M.D. Faculty: Stephen H. Dinwiddie, M.D., William G. Wood, M.D., Steven Moffic, M.D., John A. Talbott, M.D. Educational Objective: At the conclusion of this course, the participant should be able to demonstrate familiarity with theories, principles, concepts, and developments relevant to administrative psychiatry and their applications in psychiatric service systems. Course Level: This is a basic course. While not required, administrative psychiatry experience is helpful. Participants are not required to take the two-course series. The two-course series is suggested for those seeking certification. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 50. A companion course on this topic will be offered on Sat., May 18, 9-4. See Course 6 for details.

COURSE 24: THE SUBJECTIVE EXPERIENCE: CRUCIAL KEYS TO THERAPY AND TO THE HUMAN MIND. Director: Vincenzo R. Sanguineti, M.D. Faculty: Donatella Marazziti, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) better understand the structure of the subjective experience and the sources of contributing data, (2) grasp the unique character of each individual mental state, and (3) use such information to gain deeper understanding and empathy in relation to patients. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 25: THERAPEUTIC INTERVENTIONS IN EATING DISORDERS: BASIC PRINCIPLES. Director: David C. Jimerson, M.D. Faculty: Michael J. Devlin, M.D., Katherine A. Halmi, M.D., James E. Mitchell, M.D., Joel Yager, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) perform a comprehensive clinical assessment of patients with an eating disorder, (2) develop an initial treatment plan, and (3) understand the roles of short-term psychotherapy and pharmacotherapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 50. An advanced course on this topic will be offered on Sat., May 18, 9-4. See Course 10 for details.

COURSE 26: MONEY MATTERS: USING THEORY IN CLINICAL PRACTICE.Director: Cecilia M. Mikalac, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand why discussing money with patients is difficult; (2) recognize the conscious and unconscious influences of race, status, and morality in money discussions; (3) cite a range of payment policies in psychiatric practice; (4) understand and explore the basis of monetary views and practices; and (5) discuss money matters with patients without undue anxiety or defensiveness, in a manner that is both therapeutic and beneficial to the patient. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 27: ALZHEIMER'S DISEASE: ADVANCED APPROACHES TO TREATMENT.Director: William E. Reichman, M.D. Faculty: Constanine G. Lyketsos, M.D., David L. Sultzer, M.D., Peter M. Aupperle, M.D., Pierre N. Tariot, M.D., Jacobo E. Mintzer, M.D. Educational Objective: At the conclusion of this course, the participant should be able to effectively treat Alzheimer’s disease using the latest clinical techniques and medications. Course Level: This is an intermediate course. Participants should have experience and familiarity with diagnosing and treating the principal dementia syndromes, including Alzheimer’s disease. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 100.

COURSE 28: MEDICAL ETHICS 101.Director: Edmund G. Howe, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) distinguish ethical from medical issues in clinical practice, (2) use four different approaches to resolving ethical conflicts, and (3) recognize areas of ethical consensus and controversy currently faced by ethics consultants and committees in general hospital settings. Course Level: This is a basic course. No knowledge of bioethics is necessary. This is a repeat of a course given last year. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 29: BUILD YOUR OWN RELATIONAL DATABASE ELECTRONIC MEDICAL RECORD.Director: Daniel A. Deutschman, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) build a basic EMR for use with their patients to capture symptom and medication data, (2) understand the value of EMRs in improving quality of care and office efficiency, (3) understand where to get assistance in further development of EMRs, and (4) understand the added value of having the psychiatrist as the programmer. Course Level: This is an intermediate course. Participants should have modest computer experience, including e-mail, word processing, etc. Sun., May 19, 9-4; Convention Center; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 30: INTRODUCTION TO CORRECTIONAL PSYCHIATRY. Co-Directors: James E. Dillon, M.D., Lee H. Rome, M.D. Faculty: Richard S. Jackson, M.D., Sanjeev Venkataraman, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) describe the nature and purposes of criminal justice systems and correctional facilities, (2) list key findings from landmark cases in correctional psychiatry, (3) describe patterns of mental illness in correctional populations, and (4) solve common problems arising in the assessment and management of mentally ill prisoners. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 31: INTEGRATIVE PSYCHOTHERAPY SUPERVISION: BASIC TOOLS.Director: Paul Rodenhauser, M.D. Faculty: Ramona Dvorak, M.D., Albert F. Painter, Psy.D., John R. Rudisill, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify the principles of effective psychotherapy supervision, (2) summarize the levels of teaching/learning involved in the supervisory process, (3) recognize and apply appropriate supervision problem-solving strategies, and (4) demonstrate an improved capacity for use of multiple teaching methods in the supervisory process. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 32: CORE COMPETENCIES IN WORKPLACE PSYCHIATRY. APA Committee on Psychiatry in the Workplace and Academy of Organizational and Occupational Psychiatry. Director: Ronald Schouten, M.D. Faculty: Stephen H. Heidel, M.D., Steven E. Pflanz, M.D., Marcia Scott, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) describe roles psychiatrists can play in work-related matters and ways of building relationships with clients; (2) identify contractual aspects of the employer-employee relationship; and (3) list the key features of a workplace functions assessment. Course Level: This is a basic course. No previous experience or knowledge is required. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 33: PSYCHIATRIC DISORDERS IN PREGNANCY AND POSTPARTUM.Co-Directors: Shaila Misri, M.D., Kristin S. Sivertz, M.D. Faculty: Diana Carter, M.B., Maria R. Corral, M.D., Deirdre M. Ryan, M.B. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize psychiatric disorders that may occur in pregnancy and the postpartum period, and (2) identify the proper intervention strategies for such disorders. Course Level: This is an intermediate course. Participants should have basic knowledge in the area of pregnancy and postpartum. This is a repeat of a course given last year. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 34: EVIDENCE-GUIDED DUAL-DIAGNOSIS TREATMENT.Director: Andrew P. Ho, M.D. Faculty: Robert Chang, M.D., Davin A. Agustines, M.D., Carol Giannini, M.P.H., James Smith, M.D., David Haponski, M.S.W. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify target outcomes for patients with co-occurring substance disorders, and (2) use patient tracking and outcomes management methods to quantify impact of treatment. Course Level: This is an intermediate course. Participants should have Web-browser familiarity and exposure to data-management tools such as Microsoft Excel, Access, or SAS/SPSS. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25. A basic course on this will be offered on Tue., May 21, 1-5. See Course 73 for details.

COURSE 35: IRRESISTIBLE SLEEP: NARCOLEPSY UPDATE.Director: Lois Krahn, M.D. Faculty: Mark R. Hansen, M.D., Steven I. Altchuler, M.D., Jarrett W. Richardson, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize the variety of narcoleptic symptoms, (2) differentiate narcolepsy from other disorders that cause excessive daytime sleepiness, (3) appropriately order diagnostic tests, (4) understand the available treatments, and (5) review several clinical scenarios commonly encountered by psychiatrists. Course Level: This is a basic course. No experience or knowledge is required. This is a repeat of a course given last year. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 36: INTEGRATING PHARMACOTHERAPY AND PSYCHOTHERAPY.Co-Directors: Barton J. Blinder, M.D., Bernard D. Beitman, M.D. Faculty: Mark G. Barad, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify neurobiological foundations and clinical essentials of integrating pharmacother-apy and psychotherapy in the treatment of specific psychiatric disorders, (2) recognize by case examples the special determinants that facilitate and inhibit alleviation of clinical symptoms and psychological conflict with pharmacotherapy and psychotherapy combined, and (3) distinguish in a practical way among and between the various ways in which medications and psychotherapy are combined. Course Level: This is a basic course. No experience or knowledge is required. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 37: PSYCHIATRIC INTERVENTIONS IN DISASTERS: LESSONS FROM EXPERIENCE.Director: Carol S. North, M.D. Faculty: Betty Pfefferbaum, M.D., Phebe M. Tucker, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify organizational elements of community response to disasters; (2) assess individuals exposed to disasters and other major traumas; (3) differentiate normal from pathologic responses, directing individuals to appropriate interventions; (4) describe posttraumatic mental health effects on children and adults; and (5) discuss appropriate management strategies for post-disaster PTSD in children and adults. Course Level: This is a basic course. No experience or knowledge is required. This is a revision of a course given last year. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 38: MELATONIN AND LIGHT TREATMENT OF SAD, SLEEP, AND OTHER BODY CLOCK DISORDERS.Director: Alfred J. Lewy, M.D. Faculty: George Brainard, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to add melatonin and bright light to his or her treatment regimens of winter depression, shift work maladaptation, jet lag, and certain types of sleep disorders, including those of totally blind people. Course Level: This is a basic course. No experience or knowledge is required. This is a revision of a course given last year. Sun., May 19, 1-5; Convention Center; Fee: Advance $95, On-Site $125; Spaces Available: 50. A similar course on this topic will be offered on Sat., May 18, 1-5. See Course 12 for details.

COURSE 39: INTRODUCTION TO TRANSCRANIAL MAGNETIC STIMULATION.Co-Directors: Ziad H. Nahas, M.D., Leon J. Grunhaus, M.D. Faculty: Sarah H. Lisanby, M.D., Martin P. Szuba, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the physics of inducing a noninvasive neuronal depolarization, (2) address safety requirements and potential side effects, and (3) understand results of TMS clinical trials in mood and other neuropsychiatric disorders. Course Level: This is a basic course. No experience or knowledge is required. Mon., May 20, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 75.

COURSE 40: PSYCHIATRIC CONSULTATIONS IN MEDICAL SETTINGS: THE BASICS. Director: Richard L. Elliott, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) discuss the presentation, evaluation, biopsychosocial management of depression, panic disorder, delirium, dementia, alcoholism, and somatoform disorders as they arise in medical settings; (2) discuss psychiatric approaches to common legal problems arising in medical settings; and (3) discuss psychopharmacological issues in medically ill patients. Course Level: This is a basic course. However, at least six months of psychiatric training is required. Mon., May 20, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 41: RISK ASSESSMENT FOR VIOLENCE.Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify risk factors for violence, (2) improve interviewing techniques in the assessment of dangerousness, and (3) classify different types of stalkers. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100. A similar course on this topic will be offered on Thu., May 23, 8-12. See Course 99 for details.

COURSE 42: TEACHING PSYCHIATRY? LET HOLLYWOOD HELP!Director: Steven E. Hyler, M.D. Faculty: Carol A. Bernstein, M.D., Michael B. First, M.D. Educational Objective: At the conclusion of this course, the participant should be able to enhance his or her effectiveness in teaching medical students and residents through the use of selected commercial film depictions of psychopathology, diagnosis, and therapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25. A similar course on this topic will be offered on Tue., May 21, 1-5. See Course 71 for details.

COURSE 43: FAMILIES AND MEDICAL ILLNESS: AN INTEGRATIVE TREATMENT APPROACH.Director: John S. Rolland, M.D. Educational Objective: At the conclusion of this course, the participant should be knowledgeable about: (1) a comprehensive family systems model for assessment and clinical intervention with individuals, couples, and families facing chronic disorders; (2) the interface of life cycles and multigenerational patterns; (3) family beliefs related to illness; (4) factors that impede or facilitate the patient, family, and professional relationship; (5) key clinical issues for couples and families; and (6) brief interventions and other timely and cost-effective applications of the model. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 44: USING HUMANITIES TO UNDERSTAND MOOD DISORDERS.Director: Emilie S. Passow, Ph.D. Faculty: Jerome S. Gans, M.D., Steven D. Targum, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) use methods of literary interpretation to better understand mood disorders, and (2) recognize how careful attention to patterns of language provides subtle information useful for exploring the mind/brain connection, establishing trust between the physician and patient, and determining diagnosis and treatment. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

MONDAY, MAY 20, 2002

COURSE 45: PASS THE BOARDS! THE PART II ORAL EXAM.Director: James C.Y. Chou, M.D. Faculty: Gregory C. Bunt, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the format of the ABPN Part II Oral Examination, (2) recognize and avoid the most common reasons that candidates fail, and (3) identify strategies and approaches that will enable participants to pass the examination. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 125. An intermediate course on this topic will be offered on Wed., May 22, 9-4. See Course 90 for details.

COURSE 46: ADVANCED INTERVIEWING TECHNIQUES.Director: Shawn C. Shea, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) utilize five techniques for increasing validity, (2) utilize the interview strategy for eliciting suicidal ideation with the Chronological Assessment of Suicide Events (CASE Approach), (3) utilize a flexible strategy for rapidly arriving at a differential diagnosis on Axis II of the DSM-IV-TR, and (4) utilize practical strategies for nondefensively responding to awkward personal inquiries and for transforming patient anger. Course Level: This is an intermediate/advanced course. Participants should be familiar with the DSM-IV and have significant clinical experience. This is a repeat of a course given last year. Mon., May 20, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 75.

COURSE 47: TRAUMATIC BRAIN INJURY: NEUROPSYCHIATRIC ASSESSMENT.Director: Robert P. Granacher, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) perform a competent traumatic brain injury assessment for either clinical or forensic purposes, (2) understand the biomechanics and pathophysiology of brain trauma, (3) understand the various psychiatric and neuropsychiatric syndromes seen following traumatic brain injury, and (4) understand the neurobehavioral outcomes of head trauma and the impact on psychosocial functioning in both adults and children. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 48: DISORDERS OF THE SELF: DIFFERENTIAL DIAGNOSIS AND TREATMENT.Director: James F. Masterson, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) diagnose the personality disorders as disorders of the self, (2) use the intrapsychic structure to differentiate between the disorders, (3) identify and track the central psychodynamic triadic theme of the disorders of the self, (4) track this triadic theme to intervene around the defenses, and (5) identify and learn to manage countertransference. Course Level: This is an intermediate course. Participants should have some experience with the literature and patients. This is a repeat of a course given last year. Mon., May 20, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 49: ADVANCES IN NEUROPSYCHIATRY.Director: C. Edward Coffey, M.D. Faculty: Michael R. Trimble, M.D., Mark S. George, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) relate brain anatomy and chemistry to human behavior, (2) understand the role of brain imaging in the assessment of neuropsychiatric illness, and (3) diagnose and effectively manage disorders of cognition, mood, and behavior secondary to brain disorders. Course Level: This is a basic course. No experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 9-4; DoubleTree, Fee: Advance $150, On-Site $175; Spaces Available: 175.

COURSE 50: ISSUES IN TRANSPERSONAL PSYCHIATRY.Director: Bruce W. Scotton, M.D. Faculty: Allan B. Chinen, M.D., John R. Battista, M.D., William W. Foote, M.D., John F. Hiatt, M.D., Francis G. Lu, M.D., Bruce S. Victor, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) address intermediate level issues and controversies addressed by transpersonal psychiatry within the biopsychosocial model, (2) distinguish between pathological and therapeutic uses of transpersonal techniques, and (3) recognize the interactions between pharmacological, psychodynamic, and transpersonal approaches to psychiatric treatment. Course Level: This is an intermediate course. Participants should have an interest in and background reading in the field of psychiatry and spirituality. This is a repeat of a course given last year. Mon., May 20, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 51: OVERVIEW AND UPDATE OF SLEEP DISORDERS MEDICINE.Director: Karl Doghramji, M.D. Faculty: John W. Winkelman, M.D., Thomas D. Hurwitz, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand polysomnographic techniques and central mechanisms regulating sleep and wakefulness, (2) appreciate the prevalence and impact of sleep disorders, and (3) identify the major sleep disorders, their evaluation, and treatments. Course Level: This is a basic course. No previous experience or knowledge is required. Mon., May 20, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 75.

COURSE 52: TREATING MEDICAL STUDENTS AND PHYSICIANS.Co-Directors: Michael F. Myers, M.D., Leah J. Dickstein, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the role of stigma and other obstacles to care when treating medical students and physicians, (2) employ advocacy strategies on behalf of their patients, (3) appreciate the challenges when treating physicians with depression, and (4) identify transference and countertransference dynamics. Course Level: This is an intermediate course. Participants should have some experience in treating medical students and physicians. This is a repeat of a course given last year. Mon., May 20, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 53: COGNITIVE THERAPY: THE BASICS.Director: Dean Schuyler, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) think cognitively about clinical problems, (2) identify automatic thoughts in his or her patients, and (3) demonstrate a range of techniques to challenge and help a motivated patient to change meanings associated with emotional distress. Course Level: This is a basic course. No previous experience or knowledge required. This is a repeat of a course given last year. Mon., May 20, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 54: ENHANCING THE DOCTOR-PATIENT RELATIONSHIP.Director: Geoffrey M. Margo, M.D. Faculty: Katherine L. Margo, M.D., Laurel C. Milberg, Ph.D., C. Paul Scott, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the usefulness of Balint groups in residency training, (2) describe the group structure and process, (3) recognize helpful group leader interventions, and (4) understand the logistic requirements and support necessary for setting up a residency group. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Mon., May 20, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 55: ENGAGING RESISTANT AND HOSTILE PATIENTS INTO PARTICIPATORY TREATMENT.Director: David Mee-Lee, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify ways for clinicians to better deal with resistance and hostility, and (2) demonstrate skills to assess readiness and engage patients collaboratively. This is a repeat of a course given last year. Mon., May 20, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 56: BRIEF PSYCHODYNAMIC PSYCHOTHERAPY: THE CORE CONFLICTUAL RELATIONSHIP THEME METHOD.Director: Howard E. Book, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) list defining characteristics of brief psychodynamic psychotherapy (BPP); (2) differentiate BPP from emergency, crisis, and long-term psychotherapies concerning goals, frequency, duration, and therapist activity; (3) list inclusion criteria for brief psychodynamic psychotherapy; (4) develop a Core Conflictual Relationship Theme (CCRT) focus for any patient; and (5) summarize the defining characteristics of the beginning (sessions 1-4), middle (sessions 5-11), and termination (sessions 12-16) phases of the 16-session CCRT method of BPP. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Mon., May 20, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

TUESDAY, MAY 21, 2002

COURSE 57: DRUG TREATMENT OF SCHIZOPHRENIA.Director: Philip G. Janicak, M.D. Faculty: Stephen R. Marder, M.D., Rajiv Tandon, M.D., Rajiv P. Sharma, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) describe the clinically relevant aspects of the pharmacology of new and conventional antipsychotic drugs, and (2) understand their uses for acute and chronic schizophrenia. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 58: THE DETECTION OF MALINGERED MENTAL ILLNESS.Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be more skillful in detecting deception and malingering, especially in defendants pleading not guilty by reason of insanity and litigants alleging PTSD. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 59: SEXUAL DISORDERS: DIAGNOSIS AND TREATMENT.Director: Waguih W. Ishak, M.D. Faculty: Marina Bussel, M.D., Steve A. Eklund, M.D., Romana Markvitsa, M.D., Anatoly Postolov, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize the importance and the factors interfering with taking an adequate sexual history, and (2) diagnose and treat sexual disorders using a biopsychosocial approach. Course Level: This is a basic course. No previous experience or knowledge is required. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50. A similar course on this topic will be offered on Wed., May 22, 1-5. See Course 91 for details.

COURSE 60: ECT PRACTICE UPDATE.Director: Charles H. Kellner, M.D. Faculty: Richard L. Jaffe, M.D., W. Vaughn McCall, M.D., Richard D. Weiner, M.D. Educational Objective: At the conclusion of this course, the participant should be able to understand and be familiar with the most current ECT techniques. Course Level: This is an intermediate course. Participants should refer to the APA Guidelines for the Treatment of Major Depressive Disorders. Participants are encouraged to bring cases for discussion. This is a repeat of a course given last year. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 61: HOW TO USE YOUR PALM PERSONAL DIGITAL ASSISTANT IN PSYCHIATRIC PRACTICE.Director: John Luo, M.D. Faculty: Carlyle H. Chan, M.D., Charles J. Rainey, M.D., Richard A. Montgomery, M.D. Educational Objective: At the conclusion of this course, physicians who own a Palm Personal Digital Assistant (PDA) will: (1) know how to use their PDA efficiently and effectively; (2) master synchronizing data, exchanging information, installing software, converting data from external sources, and using various medical resources; and (3) become familiar with various hardware options. Course Level: This is a basic course. Participants must bring their own PDA and cradle for use in the course. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125;Spaces Available: 50.

COURSE 62: HOW TO SET UP AND RUN A JUVENILE JUSTICE CLINIC.Director: Gabriel Kaplan, M.D. Faculty: The Hon. Lee Forrester, Michael Swerdlow, Ph.D., Denise M. Williams-Johnson, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) list the most important items necessary to develop a new forensic youth service, (2) identify administrative and budgetary priorities, and (3) understand basic principles of the treatment of sex offenders and firesetters. Course Level: This is an intermediate course. Participants should have experience with treatment of adolescents, program development, or juvenile justice. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 63: DOING RESEARCH ON A SHOESTRING BUDGET.Director: Mantosh J. Dewan, M.D. Faculty: Michelle T. Pato, M.D., Edward K. Silberman, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) develop ideas into research projects, (2) develop strategies for supporting projects without grant funding, and (3) get results published. Course Level: This is a basic course. No experience or knowledge is required. This is a repeat of a course given last year. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 64: PARTIAL HOSPITALIZATION FOR PATIENTS WITH BPD.Director: Lawrence L. Kennedy, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize special problems in treating this population, (2) understand partial hospital setting for treating borderline conditions, and (3) identify basic components of an intensive partial hospital for treating borderline conditions. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Tue., May 21, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 65: DAVANLOO’S INTENSIVE SHORT-TERM DYNAMIC PSYCHOTHERAPY IN CLINICAL PRACTICE.Director: James Q. Schubmehl, M.D. Faculty: Alan R. Beeber, M.D., Tewfik Said, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) acquire a vivid sense of the forces underlying human psychopathology and a view of crucial elements of the healing process, and (2) describe main elements of Davanloo’s technique and find many aspects of the presentation useful to own clinical practice. Course Level: This is a basic course. No previous experience or knowledge is required. Tue., May 21, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 75.

COURSE 66: INTRODUCTION TO COGNITIVE-BEHAVIORAL THERAPY.Co-Directors: Robert M. Goisman, M.D., Philip G. Levendusky, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize clinical problems responsive to cognitive-behavioral methods, and (2) describe the cognitive-behavioral treatment of anxiety disorders, depression, borderline personality, eating disorders, and schizophrenia. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Tue., May 21, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 67: MED-PSYCH DRUG-DRUG INTERACTIONS: AN UPDATE.Co-Directors: Scott C. Armstrong, M.D., Kelly L. Cozza, M.D. Faculty: Jessica R. Oesterheld, M.D., David Benedek, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) use tables, literature, and the Internet to understand and appreciate significant drug-drug interactions, and (2) gain practical knowledge of pertinent food, psychiatric, and nonpsychiatric drug interactions. Course Level: This is an intermediate course. Participants should have experience with complicated medical patients. This is a repeat of a course given last year. Tue., May 21, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 150.

COURSE 68: BEING AN EFFECTIVE SCHOOL CONSULTANT.Director: Lois T. Flaherty, M.D. Faculty: Trina B. Allen, M.D., Richard L. Gross, M.D., Eugenio M. Rothe, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the types of school consultation, (2) identify frequent problems and effective interventions for them, (3) recognize the most frequent pitfalls of consultation, (4) summarize the laws and ethical guidelines applicable to school consultation, and (5) address special problems such as school avoidance, bullying, and the needs of African-American and Hispanic students. Course Level: This is an intermediate course. Participants should have knowledge of child and adolescent development and have experience evaluating children and adolescents. Tue., May 21, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 69: TRANSPERSONAL PSYCHIATRY: CLINICAL APPLICATIONS.Co-Directors: John F. Hiatt, M.D., William W. Foote, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) use techniques for inducing nonordinary states of consciousness, (2) understand the proper use of these techniques and identify persons suitable for them, and (3) acquire initial competency in their use to facilitate psychotherapy. Course Level: This is an intermediate course. Participants should have experience with spiritual practice, paranormal phenomena, or exposure to transpersonal psychiatry. This is a repeat of a course given last year. Tue., May 21, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 25.

COURSE 70: VAGAL NERVE STIMULATION.Co-Directors: Ziad H. Nahas, M.D., Mustafa M. Husain, M.D. Faculty: Linda L. Carpenter, M.D., Robert H. Howland, M.D., Mitchel A. Kling, M.D. Educational Objective: At the conclusion of the course, the participant should be able to recognize: (1) the different modalities by which the vagus nerve can be manipulated, (2) its anatomy, (3) how to program the Neuro Cybernetic Prosthesis, (4) the effects of cervical vagus nerve stimulation on epilepsy, and (5) other neuropsychiatric conditions. Course Level: This is a basic course. No previous experience or knowledge is required. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100

COURSE 71: I FOUND IT AT THE MOVIES: USING FILM CLIPS TO UNDERSTAND AND TEACH PSYCHIATRY.Director: Frederick W. Engstrom, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) find suitable film clips for teaching, (2) readily access at least 30 clips suitable for teaching, (3) lead a discussion about psychiatric diagnosis using film clips, (4) teach boundary theory using film clips, and (5) recognize the limitations and strengths of films as vehicles for teaching. Course Level: This is a basic course. No previous experience or knowledge is required. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100. A similar course on this topic will be offered on Mon., May 20, 8-12. See Course 42 for details.

COURSE 72: THE ADVANCED PRACTICE OF PSYCHOTHERAPY.Director: T. Byram Karasu, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify deficit and conflict-oriented diagnoses as universal pathology, (2) differentially use specific and generic therapeutic techniques, (3) integrate the sacred with the secular and transcend schools of psychotherapy, and (4) formulate a philosophical perspective that can further professional formation and personal growth. Course Level: This is an advanced course. Participants must be familiar with the basic concepts of psychotherapy. This is a repeat of a course given last year. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 73: ACHIEVING EFFECTIVE DUAL DIAGNOSIS TREATMENT.Director: John W. Tsuang, M.D. Faculty: Andrew P. Ho, M.D., Thomas Newton, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify the different drugs of abuse and their psychiatric manifestations, (2) recognize similarities between substance abuse and psychiatric disorders, (3) learn about the available pharmacological interventions for treatment of dual-diagnosis patients and possible interactions, and (4) use harm-reduction and total-abstinence strategies for treatment of dual-diagnosis patients. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50. An intermediate course on this topic will be offered on Sun., May 19, 1-5. See Course 34 for details.

COURSE 74: INTEGRATED MODEL FOR TREATMENT OF CO-OCCURRING PSYCHIATRIC AND SUBSTANCE DISORDERS.Director: Kenneth Minkoff, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify five philosophical/clinical barriers to integrated treatment and describe how to resolve them, (2) describe the four phases of treatment/recovery in an integrated disease and recovery model for mental illness and addiction, (3) describe and implement a protocol for diagnosing psychiatric illness in the presence of substance use disorder and vice versa, and (4) describe integrated program models for treatment of dual diagnosis and specific populations addressed by each model. Course Level: This is a basic course. No previous experience or knowledge is required. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 100.

COURSE 75: COMPUTERS IN PSYCHIATRY: A PRIMER.Director: Robert S. Kennedy, M.A. Faculty: Carlyle H. Chan, M.D., John Luo, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand how the latest hardware and software meet the needs of the contemporary psychiatrist, (2) understand the current technologies that are important for obtaining and utilizing clinical and educational information, and (3) recognize the power of the Internet as a resource for the practice of psychiatry. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 76: MULTICULTURAL APPROACH TO THE TREATMENT OF WOMEN.Director: Susan R. Downs, M.D. Faculty: Ellen Haller, M.D., Sylvia W. Olarte, M.D., Gloria Pitts, D.O., Alice C. Tso, M.D. Educational Objective: At the conclusion of this course, the participant should be more sensitive to the multiple issues encountered when working with women who are members of minority groups. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 77: ARTS AND HUMANITIES FOR SELF-RENEWAL.Director: Paul R. Miller, M.D. Faculty: Margaret Nazarey, M.S.N. Educational Objective: At the conclusion of this course, the participant should be able to: (1) describe how arts and humanities can help us to renew ourselves, our sensibilities, and our souls; (2) be shared experientially with peers; and (3) strengthen his or her ability to attend to patients and to educate students by expanding empathic understanding and selfhood. Course Level: This is a basic course. No previous experience or knowledge is required. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125;Spaces Available: 25.

COURSE 78: SEXUAL HARASSMENT: PSYCHOLOGICAL AND LEGAL ASPECTS.Director: Gail E. Robinson, M.D. Faculty: Renee L. Binder, M.D., Sharyn A. Lenhart, M.D., Michael F. Myers, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) demonstrate knowledge of the definition, etiology, consequences, and gender differences in the experience and perception of sexual harassment; (2) assess and treat the psychological impact on the victim; (3) understand the role of the expert witness in these cases; and (4) summarize basic principles for preventing sexual harassment. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Tue., May 21, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

WEDNESDAY, MAY 22, 2002

COURSE 79: COGNITIVE THERAPY FOR SEVERE MENTAL DISORDERS.Director: Jesse H. Wright, M.D. Faculty: Monica A. Basco, Ph.D., Michael E. Thase, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) utilize cognitive therapy (CT) interventions for severe depression; (2) apply CT techniques to symptoms of severe depression, psychosis, and bipolar disorder; and (3) address treatment adherence problems. Course Level: This is an intermediate course. Participants should be familiar with principles and practices of cognitive therapy. This is a revision of a course given last year. Wed., May 22, 8-12; DoubleTree; Fee Advance $95, On-Site $125; Spaces Available: 50.

COURSE 80: INSANITY DEFENSE EVALUATIONS.Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be able to systematically evaluate criminal defendants and formulate well-reasoned opinions about criminal responsibility. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Wed., May 22, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 81: INTERPERSONAL PSYCHOTHERAPY.Director: John C. Markowitz, M.D. Educational Objective: At the conclusion of this course, the participant should be able to understand the basic rationale and techniques of interpersonal psychotherapy for depression and key research supporting its use. Course Level: This is an intermediate course. Participants should be experienced in psychotherapy and the treatment of depression. Participants are required to read the following: Weissman MM, Markowitz J, Klerman GL, Comprehensive Guide to Interpersonal Psychotherapy, New York, Basic Books, 2000. This is a revision of a course given last year. Wed., May 22, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50. A basic course on this topic will be offered on Sat., May 18, 9-4. See Course 7 for details.

COURSE 82: EVIDENCE-BASED MEDICINE: AN INTRODUCTION FOR PSYCHIATRISTS.Director: Gregory E. Gray, M.D. Faculty: Letitia A. Pinson, M.D., Gabrielle F. Beaubrun, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) formulate answerable clinical questions; (2) describe the best sources for obtaining answers; (3) critically appraise reports of clinical trials, systematic reviews, and practice guidelines for validity, importance, and clinical applicability; and (4) apply the results to individual patients. Course Level: This is a basic course. No previous experience or knowledge is required. Wed., May 22, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 83: PERSONALITY DISORDERS: COMBINED INTERPERSONAL AND PHARMACOTHERAPY.Director: Roy O. Resnikoff, M.D. Educational Objective: At the conclusion of this course, the participant will learn when and how to address personality rigidities using an integration of: (1) current awareness of interpersonal personality polarities, (2) historical dynamic stories, and (3) medication for biological temperaments. In addition, the participant will learn how to therapeutically utilize his or her own personality characteristics in relationship to patients. Course Level: This is an intermediate course. Participants should have basic therapy and pharmacotherapy experience. Wed., May 22, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 84: OFFICE-BASED TREATMENT OF OPIATE-DEPENDENT PATIENTS. American Academy of Addiction Psychiatry and APA Council on Addiction Psychiatry.Co-Directors: Eric C. Strain, M.D., Thomas R. Kosten, M.D. Faculty: H. Westley Clark, M.D., David Fiellin, M.D., Herbert D. Kleber, M.D., Laura F. McNicholas, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) identify the clinically relevant pharmacological characteristics of buprenorphine, (2) describe the resources needed to set up office-based treatment with buprenorphine for patients with opioid dependence, and (3) list at least five factors to consider in determining if the patient is an appropriate candidate for office-based treatment with buprenorphine. Course Level: This is an intermediate course. Participants should have basic knowledge of diagnosis and treatment of patients with substance abuse disorders. This is a revision of a course given last year. Wed., May 22, 8-5; DoubleTree; Fee: Advance $190, On-Site $250; Spaces Available: 100.

COURSE 85: PSYCHOTHERAPY OF BORDERLINE PERSONALITY.Co-Directors: Otto F. Kernberg, M.D., Frank E. Yeomans, M.D. Faculty: John F. Clarkin, Ph.D., Eve Caligor, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the basic concepts and techniques of effective psychotherapy for borderline patients, including object-relations theory and the treatment contract, and (2) understand the strategies, tactics, and techniques of therapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course offered last year. Wed., May 22, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 75.

COURSE 86: HOW TO PRACTICE EVIDENCE-BASED PSYCHIATRY.Director: David R.S. Haslam, M.D. Faculty: John Geddes, M.R.C., Elliot M. Goldner, M.D., David M. Gardner, Pharm.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) formulate a clinical question that is both searchable and answerable in response to a therapeutic problem, (2) search effectively and efficiently for the best available published evidence to answer the therapeutic question, (3) critically appraise the acquired randomized control trial evidence for its validity and applicability, and (4) apply these findings to everyday clinical practice. Course Level: This is a basic course. Expertise in statistics or epidemiology is not required. This is a revision of a course given last year. Wed., May 22, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 87: CARING FOR REFUGEES AND SURVIVORS OF TORTURE.Director: Linda Piwowarczyk, M.D. Faculty: Michael A. Grodin, M.D., Ricardo Restrepo, M.D., Terence M. Keane, Ph.D. Educational Objective: At the conclusion of this course, participants should be able to: (1) describe the problems of refugees and survivors of torture from a human rights, public health, and psychiatric perspective; (2) recognize mental health sequelae of uprooting, torture, and related trauma; and (3) recognize the risk factors for torture and mental health problems in this patient population. Course Level: This is a basic course. No previous experience or knowledge is required. Wed., May 22, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 88: A PRACTICAL APPROACH TO HERBS AND NUTRIENTS IN PSYCHIATRY.Co-Directors: Richard P. Brown, M.D., Patricia L. Gerbarg, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize common herbs, nutrients, and hormones used by psychiatric patients, and (2) identify indications, dosages, side effects, and brands of such agents for anxiety, depression, sleep, cognitive, sexual enhancement, PMS, and migraine (based upon recent research). Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Wed., May 22, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 150.

COURSE 89: THE ASSESSMENT AND TREATMENT OF CHILD MOLESTERS.Director: John M. Bradford, M.B. Faculty: Gene G. Abel, M.D., Graham G. Glancey, M.B., J. Paul Fedoroff, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the theoretical framework for the assessment and treatment of child molesters; (2) demonstrate a working knowledge of the behavioral, pharmacological, and psychosocial treatments for the conditions; (3) obtain a basic understanding of the present ethical and legal issues involved in these conditions; and (4) understand the factors associated with sexual offender recidivism. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Wed., May 22, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 25. A similar course on this topic will be offered on Tue., May 21, 8-12. See Course 59 for details.

COURSE 90: THE BIOPSYCHOSOCIAL FORMULATION: AN APPROACH TO ORAL BOARD PRESENTATIONS.Co-Directors: Robert M. Rohrbaugh, M.D., William H. Campbell, M.D. Faculty: Catherine Chiles, M.D., Paul D. Kirwin, M.D., Richard Belitsky, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) systematically organize historical data into meaningful diagnostic categories, and (2) develop a comprehensive biopsychosocial formulation suitable for oral board presentations. Course Level: This is an intermediate course. Participants should be board-eligible. Wed., May 22, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50. A basic course on this topic will be offered on Mon., May 20, 9-4. See Course 45 for details.

COURSE 91: SLEEP MEDICINE UPDATE: ADVANCED TOPICS.Director: Thomas D. Hurwitz, M.D. Faculty: Max Hirshkowitz, Ph.D., Lois Krahn, M.D. Educational Objective: At the conclusion of the course, the participant should: (1) be familiar with recent information on basic sleepy physiology, pharmacological influences on sleep, and clinically relevant topics of parasomnias and narcolepsy, and (2) be able to interpret the reports generated by clinical sleep laboratory studies. Course Level: This is an intermediate course. Participants should be familiar with basic concepts of sleep architecture and sleep disorders and should have completed the basic course on sleep medicine. Wed., May 22, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50. A basic course on this topic will be offered on Mon., May 20, 1-5. See Course 51 for details.

COURSE 92: COGNITIVE THERAPY FOR SCHIZOPHRENIA.Co-Directors: Jesse H. Wright, M.D., Aaron T. Beck, M.D. Faculty: Jan L. Scott, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) describe the biological-cognitive-behavioral model for treatment of schizophrenia, (2) use cognitive therapy methods for treating positive and negative symptoms of schizophrenia, and (3) employ cognitive therapy methods for improving medication compliance. Course Level: This is an intermediate level course. Participants should have a basic understanding of cognitive-behavioral principles. Wed., May 22, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 93: ADVANCED ASSESSMENT AND TREATMENT OF ADD.Director: Thomas E. Brown, Ph.D. Faculty: Jefferson B. Prince, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand emerging new models of ADD and research-based modifications in its assessment, (2) adequately assess complicated cases of ADD, (3) understand how medication treatments should be modified to deal with psychiatric and/or medical complications, and (4) develop treatment plans to address complicated ADD across the life cycle. Course Level: This is an advanced course. Participants should have basic professional education and clinical experience in the assessment and treatment of ADHD. This is a revision of a course given last year. Wed., May 22, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 150.

COURSE 94: CPT CODING AND DOCUMENTATION 2002.Director: Chester W. Schmidt Jr., M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand both evaluation and management codes, as well as the psychiatric evaluation and therapeutic procedure codes, and (2) document the provision of services denoted by the above two sets of codes. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Wed., May 22,1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 95: IMPROVING MEDIA COVERAGE OF SUICIDE: THE ROLE OF THE PSYCHIATRIST.American Foundation for Suicide Prevention.Co-Directors: Herbert Hendin, M.D., Kathleen Jamison, Ph.D. Faculty: Dwight L. Evans, M.D., Madelyn Gould, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the dangers of bad coverage of suicide and the benefits of good coverage, (2) recognize the difference in actual stories, and (3) advise the press on how to avoid one and achieve the other. Course Level: This is an advanced course. Participants should have knowledge of suicide. Wed., May 22, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

COURSE 96: TREATMENT OF CREATIVE PATIENTS.Director: Albert Rothenberg, M.D. Educational Objectives: At the conclusion of this course, the participant should be able to: (1) understand specific types of cognitive creative processes, (2) evaluate salient research and understand relationships between creativity and psychopathology, and (3) effectively treat creative patients. Course Level: This is an intermediate course. Participants should have clinical experience, knowledge of research principles, and creative interests. Wed., May 22, 1-5; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 25.

THURSDAY, MAY 23, 2002

COURSE 97: ETHICAL DECISION MAKING IN CLINICAL PRACTICE.Director: Stephen A. Green, M.D. Faculty: Sydney Bloch, M.D. Educational Objective: At the conclusion of this course, participants should: (1) be versed in the theoretical underpinnings of ethical decision making, and (2) be able to apply that knowledge to clinical situations. Course Level: This is a basic course. No previous experience or knowledge is required. Thu., May 23, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 98: THE MISSING PIECE OF THE PUZZLE: TIC DISORDERS IN ADULTS WITH OCD OR ADD.Director: Maria A. Pugliese, M.D. Faculty: J. Paul Hieble, Ph.D., Michael N. Rubenstein, M.D., Orrin Palmer, M.D., Sue Levi-Pearl, Mary Lou Reaver, R.N. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize simple and complex motor and vocal tics in adults with other disorders, (2) know how to differentiate between compulsions and complex motor tics, (3) understand the basic anatomy and pharmacology of tic disorders, and (4) learn effective treatments. Course Level: This is a basic course. No previous experience or knowledge is required. Thu., May 23, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50.

COURSE 99: ASSESSING THE RISK FOR VIOLENCE.Director: Bradley R. Johnson, M.D. Faculty: Judith Becker, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) summarize what is currently known about the prediction of future violence in both patient and forensic settings, and (2) learn how to administer, or where to obtain, a number of violence-risk prediction scales. Course Level: This is a basic course. No previous experience or knowledge is required. Thu., May 23, 8-12; DoubleTree; Fee: Advance $95, On-Site $125; Spaces Available: 50. A similar course on this topic is being offered on Mon., May 20, 8-12. See Course 41 for details.

COURSE 100: BACK TO THE FUTURE: THE EVOLUTIONARY FRAMEWORK FOR PSYCHIATRY.Director: John R. Evaldson, M.D. Faculty: Mark Erickson, M.D., Annette J. Hollander, M.D., David Mullen, M.D., Daniel R. Wilson, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) understand the fundamental ways evolution has organized human development and psychopathology, and (2) start to use that to organize other knowledge and treatment. Course Level: This is an intermediate course. Knowledge of human development and psychopathology typical for psychiatrists, psychologists, or other professionals is required. Thu., May 23, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 101: PTSD: AN HISPANIC UPDATE OF A UNIVERSAL PROBLEM (IN SPANISH).American Society of Hispanic Psychiatry. Director: Luis F. Ramirez, M.D. Faculty: Jose M. Canive, M.D., Dora Cardona, M.D., Roxana Galeno, M.D., Daniel Toledo, M.D., Alarçon Renato, M.D. Educational Objective: At the conclusion of this course, the participant should be able to: (1) recognize the basic symptoms of posttraumatic stress disorder, (2) discuss the different types of PTSD, (3) be familiar with the concept of resilience, (4) be familiar with the psychobiology of PTSD, and (5) organize a plan for treatment of patients with PTSD. Course Level: This is a basic course. No previous experience or knowledge is required. Participants must speak and understand Spanish. Thu., May 23, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 50.

COURSE 102: THE CONCEPTUAL BASIS OF PSYCHIATRY.Co-Directors: S. Nassir Ghaemi, M.D., David H. Brendel, M.D. Director: At the conclusion of this course, the participant should be able to understand conceptual and philosophical aspects of psychiatric practice and research. Course Level: This is a basic course. No previous experience or knowledge is required. Thu., May 23, 9-4; DoubleTree; Fee: Advance $150, On-Site $175; Spaces Available: 25.